Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Cancer Res. 2011 Mar 1;71(5):1573–1583. doi: 10.1158/0008-5472.CAN-10-3126

Figure 1. Selectivity of mTORC1/mTORC2 inhibitors, OXA-01 and OSI-027.

Figure 1

A Structures for OXA-01 and OSI-027 are shown. B. In vitro IC50 values for a representative set of kinases are shown. C. Selectivity was further demonstrated in cell-based assays using phosphorylated kinases or downstream effectors as a measure of activity.